Streetbeat News

Revenues

ROOT

Analysts have provided mixed ratings for Root (NASDAQ:ROOT) over the past three months, with a recent trend of lowering price targets. The average 12-month price target has decreased by 6.85% to $73.4. Despite impressive revenue growth, Root faces challenges with profitability, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 7:01 pm

HG

Hamilton Insurance Group (NYSE:HG) has been analyzed by six analysts, with most ratings being somewhat bullish. The average 12-month price target has increased to $22.17, reflecting a 9.75% rise. The company shows strong financial performance with high revenue growth, net margin, and ROE.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 7:01 pm

IRM

Iron Mountain (NYSE:IRM) has significantly outperformed the market over the past 5 years, with an annualized return of 29.43%. A $1000 investment in IRM 5 years ago would now be worth $3,664.31. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 7:00 pm

CVE

Cenovus Energy (NYSE:CVE) has delivered an average annual return of 15.83% over the past 5 years, outperforming the market by 1.84% annually. A $1000 investment in CVE 5 years ago would be worth $2,106.76 today.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 7:00 pm

EQH

Equitable Holdings (NYSE:EQH) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased by 10.2% to $51.43. Analysts have adjusted their ratings and price targets, reflecting their views on EQH's market performance. Despite strong revenue growth and return on equity, EQH faces challenges with net margin, return on assets, and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 7:00 pm

MELI

Goldman Sachs projects a 30% upside for MercadoLibre (MELI) due to strong growth in gross merchandise value and payment volume. Despite potential margin pressure from new logistics facilities, the firm maintains a Buy rating with a price target of $2,620.

Portfolio Pulse from Vandana Singh

October 10, 2024 | 6:47 pm

CVS

WBA

Barclays has upgraded CVS Health Inc (NYSE:CVS) to Overweight, citing resilience in the face of macroeconomic pressures and potential market share gains. CVS is expected to benefit from Medicare margin expansion and Walgreens' store closures. The price target is raised to $82.

Portfolio Pulse from Vandana Singh

October 10, 2024 | 6:41 pm

CMC

Commercial Metals (NYSE:CMC) has significantly outperformed the market over the past 5 years, with an annualized return of 22.13%. A $1000 investment in CMC 5 years ago would now be worth $2,817.33, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 6:30 pm

ACN

Accenture (NYSE:ACN) has outperformed the market over the past 10 years with an average annual return of 16.84%, resulting in a $100 investment growing to $472.15. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 6:30 pm

CNPOF

HITI

Cheech & Chong are opening their first cannabis shop in Maine, while new cannabis stores are also opening in Connecticut, New York, and Toronto. RIV Capital Inc. and High Tide Inc. are expanding their cannabis retail operations.

Portfolio Pulse from Jelena Martinovic

October 10, 2024 | 6:20 pm